HYPERSPECTRAL IMAGING TO ASSESS AND PREDICT DIABETIC FOOT ULCERS
高光谱成像评估和预测糖尿病足溃疡
基本信息
- 批准号:7608206
- 负责人:
- 金额:$ 0.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-04-01 至 2007-09-16
- 项目状态:已结题
- 来源:
- 关键词:CaringChemicalsClinicalComputer Retrieval of Information on Scientific Projects DatabaseDataDiabetes MellitusDiabetic Foot UlcerFoot DiseasesFoot UlcerFrequenciesFundingGrantHealedHealth Care CostsImageInstitutionLifeLongitudinal StudiesMedicalMetabolicMethodsMonitorMorbidity - disease rateMulticenter StudiesOutcome MeasurePatientsQuality of lifeResearchResearch PersonnelResourcesRiskSmall Business Technology Transfer ResearchSourceSystemTissuesTreatment EfficacyUlcerUnited States National Institutes of Healthbasecost effectivediabeticfoothealingmortalitypreventtool
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Foot disease complications seriously impact lives of people with diabetes. A quantitative method to evaluate efficacy of therapy, or better, to define tissue at risk & prevent initial ulcer formation would be highly beneficial. This study, part of a multicenter study by HyperMed Inc. (STTR, funded by the NIH) has a long-term objective to reduce frequency of foot ulceration by developing Medical HyperSpectral Imaging (MHSI). The MHSI camera-based system (manufactured by HyperMed, Inc.) is used in this study to identify tissue at risk for ulceration, evaluate the healing capability of an ulcer & monitor treatment efficacy. MHSI provides an image with spectral data inherent in each pixel which reflects the presence & concentration of various chemical species.
Specific aims of this study are to: 1) assess healing or progression in 10 type 1 and 12 type 2 diabetic patients with manifest foot ulcers, 2) study 30 type 1 and 40 type 2 diabetic patients at high risk for foot ulceration in a longitudinal study aimed at predicting ulceration, 3) validate merit in further developing MHSI using clinical outcome measures & comparing MHSI with existing methods (TcPO2) to determine advantages & limitations of MHSI in clinical foot care. MHSI is potentially a cost effective, easy to use, turn-key camera-based tool, which delivers metabolic information in a simple to interpret image. It will positively impact the quality of life of people with diabetes, impacting morbidity & mortality & lowering overall healthcare costs.
这个子项目是许多研究子项目中的一个
由NIH/NCRR资助的中心赠款提供的资源。子项目和
研究者(PI)可能从另一个NIH来源获得了主要资金,
因此可以在其他CRISP条目中表示。所列机构为
研究中心,而研究中心不一定是研究者所在的机构。
足部疾病并发症严重影响糖尿病患者的生活。评估治疗效果的定量方法,或更好地,以确定组织的风险和防止初始溃疡形成将是非常有益的。本研究是HyperMed Inc.多中心研究的一部分。(STTR由NIH资助)的长期目标是通过开发医学超光谱成像(MHSI)来降低足部溃疡的频率。 基于MHSI相机的系统(由HyperMed,Inc.在本研究中用于识别有溃疡风险的组织,评估溃疡的愈合能力并监测治疗效果。 MHSI提供了一个图像,每个像素中固有的光谱数据反映了各种化学物质的存在和浓度。
这项研究的具体目标是:1)评估10名具有明显足部溃疡的1型和12名2型糖尿病患者的愈合或进展,2)在旨在预测溃疡的纵向研究中研究30名具有足部溃疡高风险的1型和40名2型糖尿病患者,3)使用临床结果测量验证进一步开发MHSI的优点,并将MHSI与现有方法(TcPO 2)进行比较,以确定MHSI在临床足部护理中的优点和局限性。 MHSI可能是一种具有成本效益,易于使用,基于相机的交钥匙工具,它可以在简单的图像中提供代谢信息。它将对糖尿病患者的生活质量产生积极影响,影响发病率和死亡率,降低整体医疗成本。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BRIAN L DAVIS其他文献
BRIAN L DAVIS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BRIAN L DAVIS', 18)}}的其他基金
XXth Congress of International Society of Biomechanics
国际生物力学学会第二十届大会
- 批准号:
7005321 - 财政年份:2005
- 资助金额:
$ 0.99万 - 项目类别:
Diabetes Initiative for Applied Biomedical Engineering
应用生物医学工程糖尿病倡议
- 批准号:
6936568 - 财政年份:2003
- 资助金额:
$ 0.99万 - 项目类别:
Diabetes Initiative for Applied Biomedical Engineering
应用生物医学工程糖尿病倡议
- 批准号:
7088991 - 财政年份:2003
- 资助金额:
$ 0.99万 - 项目类别:
Diabetes Initiative for Applied Biomedical Engineering
应用生物医学工程糖尿病倡议
- 批准号:
6750078 - 财政年份:2003
- 资助金额:
$ 0.99万 - 项目类别:
Diabetes Initiative for Applied Biomedical Engineering
应用生物医学工程糖尿病倡议
- 批准号:
7256222 - 财政年份:2003
- 资助金额:
$ 0.99万 - 项目类别:
Diabetes Initiative for Applied Biomedical Engineering
应用生物医学工程糖尿病倡议
- 批准号:
6602529 - 财政年份:2003
- 资助金额:
$ 0.99万 - 项目类别:
相似海外基金
Plastic Chemicals in Pediatric Cardiopulmonary Bypass: Evaluating Cardiac Toxicity and Investigating Clinical Alternatives
儿科心肺绕道中的塑料化学品:评估心脏毒性并研究临床替代方案
- 批准号:
10677964 - 财政年份:2023
- 资助金额:
$ 0.99万 - 项目类别:
REGISTRATION, STORAGE AND DISTRIBUTION OF CHEMICALS AND DRUGS FOR PRE-CLINICAL DISCOVERY, EVALUATION AND DEVELOPMENT
用于临床前发现、评估和开发的化学品和药物的注册、储存和分配
- 批准号:
10797066 - 财政年份:2023
- 资助金额:
$ 0.99万 - 项目类别:
REGISTRATION, STORAGE AND DISTRIBUTION OF CHEMICALS AND DRUGS FOR PRE-CLINICAL DISCOVERY EVALUATION AND DEVELOPMENT
用于临床前发现评估和开发的化学品和药物的注册、储存和分配
- 批准号:
10458181 - 财政年份:2021
- 资助金额:
$ 0.99万 - 项目类别:
REGISTRATION, STORAGE AND DISTRIBUTION OF CHEMICALS AND DRUGS FOR PRE-CLINICAL DISCOVERY EVALUATION AND DEVELOPMENT
用于临床前发现评估和开发的化学品和药物的注册、储存和分配
- 批准号:
10577410 - 财政年份:2021
- 资助金额:
$ 0.99万 - 项目类别:
Development and clinical application of low molecular chemicals that modulate myosin light chain kinase for the treatment of heart failure with preserved ejection fraction
调节肌球蛋白轻链激酶的低分子化学药物治疗射血分数保留性心力衰竭的开发及临床应用
- 批准号:
18H04050 - 财政年份:2018
- 资助金额:
$ 0.99万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Manufacture of Bulk Chemicals and Bulk Pharmaceutical Ingredients for Preclinical and Clinical Studies
用于临床前和临床研究的散装化学品和散装药物成分的制造
- 批准号:
9915787 - 财政年份:2017
- 资助金额:
$ 0.99万 - 项目类别:
Manufacture of Bulk Chemicals and Bulk Pharmaceutical Ingredients for Preclinical and Clinical Studies
用于临床前和临床研究的散装化学品和散装药物成分的制造
- 批准号:
10551125 - 财政年份:2017
- 资助金额:
$ 0.99万 - 项目类别:
Manufacture of Bulk Chemicals and Bulk Pharmaceutical Ingredients for Preclinical and Clinical Studies
用于临床前和临床研究的散装化学品和散装药物成分的制造
- 批准号:
10329855 - 财政年份:2017
- 资助金额:
$ 0.99万 - 项目类别:
Manufacture of Bulk Chemicals and Bulk Pharmaceutical Ingredients for Preclinical and Clinical Studies
用于临床前和临床研究的散装化学品和散装药物成分的制造
- 批准号:
10075834 - 财政年份:2017
- 资助金额:
$ 0.99万 - 项目类别:
Title: Registration, Storage and Distribution of Chemicals and Drugs for Pre-Clinical Discovery, Evaluation and Development
标题:用于临床前发现、评估和开发的化学品和药物的注册、储存和分销
- 批准号:
9433586 - 财政年份:2017
- 资助金额:
$ 0.99万 - 项目类别: